Submitted by Anonymous (not verified) on 8 September 2023 - 10:15
Human medicines European public assessment report (EPAR): Aripiprazole Mylan Pharma (previously Aripiprazole Pharmathen), aripiprazole, Schizophrenia;Bipolar Disorder, Date of authorisation: 30/06/2015, Revision: 16, Status: Authorised
Source: